Lifesci Capital cut shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a report issued on Monday morning, PriceTargets.com reports. Other analysts have also issued reports about the company. EF Hutton Acquisition Co. I reiterated a buy rating and set a $16.00 price target on shares […]
Guggenheim cut shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from a buy rating to a neutral rating in a research note released on Monday, The Fly reports. RAIN has been the subject of a number of other research reports. EF Hutton Acquisition Co. I restated a buy rating and set a $16.00 target price […]
Rain Oncology Inc. (NASDAQ:RAIN – Get Rating) insider Boxer Capital, Llc sold 995,000 shares of Rain Oncology stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $1.25, for a total transaction of $1,243,750.00. Following the sale, the insider now directly owns 1,152,212 shares in the company, valued […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Rating) major shareholder Boxer Capital, Llc purchased 70,000 shares of the stock in a transaction that occurred on Thursday, October 13th. The shares were acquired at an average price of $4.65 per share, for a total transaction of $325,500.00. Following the completion of the transaction, the insider now directly […]
Tyra Biosciences’ (NASDAQ:TYRA – Get Rating) lock-up period will end on Monday, March 14th. Tyra Biosciences had issued 10,800,000 shares in its initial public offering on September 15th. The total size of the offering was $172,800,000 based on an initial share price of $16.00. After the expiration of the company’s lock-up period, company insiders and […]